{"id":193536,"date":"2024-01-31T16:11:59","date_gmt":"2024-01-31T10:41:59","guid":{"rendered":"https:\/\/newsmakhani.com\/?p=193536"},"modified":"2024-01-31T16:11:59","modified_gmt":"2024-01-31T10:41:59","slug":"cci-approves-proposed-subscription-of-compulsorily-convertible-preference-shares-b-ccps-b-in-api-holdings-ltd-by-cdpq-private-equity-asia-pte-ltd","status":"publish","type":"post","link":"https:\/\/newsnarad.com\/pa\/cci-approves-proposed-subscription-of-compulsorily-convertible-preference-shares-b-ccps-b-in-api-holdings-ltd-by-cdpq-private-equity-asia-pte-ltd\/","title":{"rendered":"CCI approves proposed subscription of Compulsorily Convertible Preference Shares (B) (CCPS B) in API Holdings Ltd. by CDPQ Private Equity Asia Pte Ltd."},"content":{"rendered":"

\u0a2e\u0a3e\u0a2b\u0a3c \u0a15\u0a30\u0a28\u0a3e, \u0a07\u0a39 \u0a16\u0a2c\u0a30 \u0a24\u0a41\u0a39\u0a3e\u0a21\u0a40 \u0a2c\u0a47\u0a28\u0a24\u0a40 \u0a2d\u0a3e\u0a38\u0a3c\u0a3e \u0a35\u0a3f\u0a71\u0a1a \u0a09\u0a2a\u0a32\u0a2c\u0a27 \u0a28\u0a39\u0a40\u0a02 \u0a39\u0a48\u0964 \u0a15\u0a3f\u0a30\u0a2a\u0a3e \u0a15\u0a30\u0a15\u0a47 \u0a07\u0a71\u0a25\u0a47 \u0a26\u0a47\u0a16\u0a4b\u0964<\/a><\/p>

<\/p>\n

\n
Delhi: 31 JAN 2024\u00a0<\/strong><\/h5>\n<\/div>\n

The Competition Commission of India (CCI) has approved proposed subscription of CCPS B in API Holdings Ltd. by CDPQ Private Equity Asia Pte Ltd.<\/p>\n

CDPQ Private Equity Asia Pte Ltd (Acquirer<\/strong>) is a direct wholly owned subsidiary of CDPQ and is located in Singapore. CDPQ is a Canadian institutional fund, which acts as a long-term institutional investor that manages funds primarily for public and para-public pension and insurance plans in Canada. The Acquirer, CDPQ and their affiliates are collectively referred to as the \u2018Acquirer Group<\/strong>\u2019.<\/p>\n

API Holdings Ltd. (Target<\/strong>), through its subsidiaries, is engaged in operating business relating to healthcare services such as (i) an online e-commerce marketplace through a mobile application as well as a website called \u2018PharmEasy\u2019; (ii) B2B (i.e., wholesale) sale and purchase of pharmaceutical and nutraceutical products and also undertakes activities of warehousing, storing and packaging of such products; and (iii) providing diagnostic and healthcare services to customers, directly, through the laboratories\/collection centers owned and operated by it or through partner laboratories\/collection centers through subcontracting arrangements with third parties.<\/p>\n

The Target proposes to raise capital through issuance of CCPS B by way of a Rights Issue. The Acquirer is an existing investor in the Target and is a pre-emption right holder. The Acquirer shall subscribe to the Rights Issue by way of a primary subscription accompanied with certain rights. (Proposed Combination<\/strong>).<\/p>\n

Detailed order of the CCI will follow.<\/p>","protected":false},"excerpt":{"rendered":"

\u0a2e\u0a3e\u0a2b\u0a3c \u0a15\u0a30\u0a28\u0a3e, \u0a07\u0a39 \u0a16\u0a2c\u0a30 \u0a24\u0a41\u0a39\u0a3e\u0a21\u0a40 \u0a2c\u0a47\u0a28\u0a24\u0a40 \u0a2d\u0a3e\u0a38\u0a3c\u0a3e \u0a35\u0a3f\u0a71\u0a1a \u0a09\u0a2a\u0a32\u0a2c\u0a27 \u0a28\u0a39\u0a40\u0a02 \u0a39\u0a48\u0964 \u0a15\u0a3f\u0a30\u0a2a\u0a3e \u0a15\u0a30\u0a15\u0a47 \u0a07\u0a71\u0a25\u0a47 \u0a26\u0a47\u0a16\u0a4b\u0964 Delhi: 31 JAN 2024\u00a0 The Competition Commission of India (CCI) has approved proposed subscription of CCPS B in API Holdings Ltd. by CDPQ Private Equity Asia Pte Ltd. CDPQ Private Equity Asia Pte Ltd (Acquirer) is a direct wholly owned […]<\/p>\n","protected":false},"author":18,"featured_media":3314,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[109,122],"tags":[106090,25024,56731],"class_list":["post-193536","post","type-post","status-publish","format-standard","has-post-thumbnail","category-national","category-news","tag-acquirer-group","tag-competition-commission-of-india","tag-news-makhani"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t